Researcher
Valerie Fonteyne
- Keywords:bladder cancer, prostate cancer, Radiotherapy
- Disciplines:Morphological sciences
Affiliations
- Department of Human Structure and Repair (Department)
Member
From1 Oct 2018 → Today - Department of Radiation oncology and experimental cancer research (Department)
Member
From1 Oct 2015 → 30 Sep 2018
Projects
1 - 1 of 1
- Combining cystectomy and external beam radiotherapy for patients with muscle invasive bladder cancer: a phase II trialFrom1 Oct 2016 → 30 Sep 2021Funding: Nonprofit institution or equivalents
Publications
1 - 10 of 21
- Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort(2024)
Authors: Renée Bultijnck, Mieke Van Hemelrijck, Valerie Fonteyne, Lorenzo Livi, Barbara Alicja Jereczek-Fossa, Hossein Hemmatazad, Michael Mayinger, Heike Peulen, Luc Verbeke, Sara Ramella, et al.
- Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study(2023)
Authors: Renée Bultijnck, Elke Rammant, Karel Decaestecker, Valerie Fonteyne, Nicolaas Lumen, Piet Ost, Benedicte Deforche
- Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study(2023)
Authors: Philipp Heumann, Miguel E. Aguado-Barrera, Barbara Avuzzi, David Azria, Erik Briers, Renée Bultijnck, Ananya Choudhury, Dirk De Ruysscher, Marie-Pierre Farcy-Jacquet, Valerie Fonteyne, et al.
- Microbiome and metabolome dynamics during radiotherapy for prostate cancer(2023)
Authors: Willeke Danckaert, Mathieu Spaas, Nora Sundahl, Aurélie De Bruycker, Valerie Fonteyne, Ellen De Paepe, Carlos De Wagter, Lynn Vanhaecke, Piet Ost
- Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types(2023)
Authors: Elnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, Leila Dorling, Tim Rattay, Laura Fachal, Holly Summersgill, Laura Martínez-Calvo, Ceilidh Welsh, Tom Dudding, et al.
- High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer(2022)
Authors: Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, Adam Webb, Petra Seibold, Claudio Fiorino, Cesare Cozzarini, Liv Veldeman, Renée Bultijnck, Valerie Fonteyne, et al.
- Physical activity and health-related quality of life from diagnosis to one year after radical cystectomy in patients with bladder cancer : a longitudinal cohort study(2022)
Authors: Elke Rammant, Ann Van Hecke, Jelle Van Cauwenberg, Karel Decaestecker, Lindsay Poppe, Beth Russel, Renée Bultijnck, Maarten Albersen, Sofie Verhaeghe, Mieke Van Hemelrijck, et al.
Pages: 395 - 404 - Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer(2022)
Authors: Sarah L. Kerns, Ashley Amidon Morlang, Sharon M. Lee, Derick R. Peterson, Brian Marples, Hong Zhang, Kevin Bylund, Doug Rosenzweig, William Hall, Kim De Ruyck, et al.
Pages: 75 - 82 - A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer(2020)
Authors: Elise De Bleser, Ruben Willems, Karel Decaestecker, Lieven Annemans, Aurélie De Bruycker, Valerie Fonteyne, Nicolaas Lumen, Filip Ameye, Ignace Billiet, Steven Joniau, et al.
- A systematic review of the role of definitive local treatment in patients with clinically lymph node-positive prostate cancer(2019)
Authors: Eugenio Ventimiglia, Thomas Seisen, Firas Abdollah, Alberto Briganti, Valerie Fonteyne, Nicholas James, Mack Roach, George N. Thalmann, Karim Touijeri, Ronald C. Chen, et al.
Pages: 294 - 301